Element Biosciences

Sales Representative - Dallas

Remote

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Life Sciences, GenomicsIndustries

Requirements

Candidates must possess a Bachelor's degree in Biology or Genetics, or a Master's degree or Ph.D., and have at least four years of commercial sales experience or equivalent laboratory experience combined with customer-facing experience. Capital equipment sales experience is required, along with a strong Genetics and Molecular Biology foundation and preferred knowledge of Next Generation Sequencing and Genotyping methods. Deep knowledge and relationships with decision makers/influencers and leading researchers in the sequencing and spatial biology community are also desired.

Responsibilities

The Sales Representative will develop a strong understanding of Element technology, establish and execute strategies for obtaining new customers and maintaining/growing existing accounts to meet and exceed revenue goals in North Texas, OK, CO, KS, and NM, take an analytical approach to solving issues and opportunities, present versatile solutions during customer negotiations, learn and adapt from experiences, work effectively in a team environment to drive revenue, and manage customer relationships post-sale.

Skills

Sales
Customer Acquisition
Account Management
High-Throughput Instrument Platforms
Consumables Sales
Genetics
Molecular Biology
Next Generation Sequencing
Genotyping
Networking
Customer Negotiation
Strategic Planning

Element Biosciences

Next-generation sequencing technology provider

About Element Biosciences

Element Biosciences focuses on next-generation sequencing (NGS) technology, offering the AVITI System, a compact benchtop device that provides high-quality sequencing at a low cost of $1 per million reads. This system is designed for various clients, including academic researchers and pharmaceutical companies, and delivers industry-leading accuracy. Element Biosciences stands out by partnering with other biotech firms, like QIAGEN, to provide complete NGS workflows and by offering the 2023 AVITI for All Grant, which gives free sequencing for diverse applications. The company's goal is to make high-quality sequencing accessible and affordable to accelerate advancements in biotechnology.

Key Metrics

San Diego, CaliforniaHeadquarters
2017Year Founded
$659.5MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

100% company-paid medical, dental, & vision coverage
Flexible spending & health savings accounts
Premier mental health care
401(k) with immediately vested 4% company match
Company-paid Life and AD&D insurance
Stock option grants
Flexible time off
10 paid annual holidays
8-weeks paid parental leave

Risks

Increased competition from companies like Illumina may impact market share.
Rapid technological advancements require continuous innovation, straining resources.
High cost of AVITI24 may limit adoption among smaller research institutions.

Differentiation

Element Biosciences offers the AVITI System, a low-cost, high-quality sequencing platform.
The company's proprietary technology improves signal-to-noise ratio, enhancing sequencing data quality.
Strategic partnerships with firms like QIAGEN provide comprehensive NGS workflows for clients.

Upsides

AVITI24 platform integrates sequencing and multiomic analysis, revolutionizing cancer research.
Record growth in AVITI System installations indicates strong market demand and acceptance.
Recent executive appointments highlight commitment to leveraging AI for product optimization.

Land your dream remote job 3x faster with AI